P De Wals
Overview
Explore the profile of P De Wals including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Belanger-Gravel A, Paquette M, Espin-Espinoza A, Janezic I, Desroches S, De Wals P
Public Health
. 2022 Nov;
213:28-33.
PMID: 36332414
Objectives: This study aimed to examine the factors associated with low sugar-sweetened beverage (SSB) consumption and intention to avoid these products as well as investigate the role of different types...
2.
Deceuninck G, Lefebvre B, Tsang R, Betala-Belinga J, De Serres G, De Wals P
Vaccine
. 2019 Jun;
37(31):4243-4245.
PMID: 31239214
In the Saguenay-Lac-Saint-Jean region of Quebec, 83% of the population ≤20 years (n ≅ 59,500) was immunized in 2014 with the four-component Serogroup B meningococcal vaccine to control a long-lasting...
3.
De Wals P, LeMeur J, Ayukawa H, Proulx J
Int J Circumpolar Health
. 2019 Mar;
78(1):1599269.
PMID: 30924406
Otitis media (OM) and their sequelae are a major health issue in the Inuit population of Nunavik, Quebec. Hypotheses of the study were: (i) early onset OM leads to repeated...
4.
Le Meur J, Ayukawa H, Proulx J, De Wals P
Vaccine
. 2018 Jul;
36(34):5180-5186.
PMID: 30026032
Background: Otitis media (OM) constitutes an important public health problem in the Inuit population of Nunavik, Northern Quebec. One of the objectives of the childhood pneumococcal vaccination program is to...
5.
Anderson G, Deceuninck G, Zhou Z, Boucher F, Bonnier Viger Y, Gilca R, et al.
Epidemiol Infect
. 2017 Aug;
145(13):2770-2776.
PMID: 28803551
Streptococcus pneumoniae is an important cause of community-acquired pneumonia and pneumococcal conjugate vaccines (PCVs) may reduce this burden. This study's goal was to analyse trends in lower respiratory tract infections...
6.
Le Bodo Y, Blouin C, Dumas N, De Wals P, Lague J
Obes Rev
. 2017 May;
18(9):967-986.
PMID: 28557192
Over the last years, many actions have been implemented in the Canadian province of Quebec to prevent health issues related to diet, physical activity and obesity. As a new public...
7.
Zhou Z, Deceuninck G, Lefebvre B, De Wals P
Can J Infect Dis Med Microbiol
. 2017 Mar;
2017:4347206.
PMID: 28246534
In Canada, the current recommendation is to offer PPV23 to adults ≥ 65 years. PCV13 is now licensed for adults. Invasive pneumococcal disease (IPD) cases in adults 65-74 years of...
8.
Zhou Z, Gilca R, Deceuninck G, Boucher F, Charest H, De Wals P
Epidemiol Infect
. 2015 Sep;
144(5):1035-44.
PMID: 26381086
Young age, adverse environmental conditions and infectious agents are established risk factors of lower respiratory tract infection (LRTI), whereas pneumococcal conjugate vaccines may be protective. To explore their relative role...
9.
De Wals P, Carbonneau M, Payette H, Niyonsenga T
Can J Infect Dis
. 2012 Apr;
7(5):296-300.
PMID: 22514453
Objectives: To evaluate the use of influenza and pneumococcal vaccines in long term care facilities. Design: Cross-sectional survey in a random sample of 30 facilities in two regions of Quebec....
10.
De Wals P, Blackburn M, Guay M, Bravo G, Blanchette D, Douville-Fradet M
Can J Infect Dis
. 2007 Dec;
12(1):27-32.
PMID: 18159314
Objective: To estimate the nonhospital costs of treating chickenpox and to ascertain the opinion of parents regarding the usefulness of vaccination. Design: Retrospective postal survey. Setting: Province of Quebec. Participants:...